Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Verma Drugs is a leading Greek pharmaceutical and medical technology company specializing in the development, manufacturing, and distribution of high-quality solutions for patients with End-Stage Renal Disease (ESRD). Established in 1978 by chemist and pharmacist Komninos Gamvroulis, the company operates a state-of-the-art 7,000 m² manufacturing facility in Koropi, Greece, producing a comprehensive portfolio of dialysis solutions, bicarbonate cartridges, and disinfection systems. Verma Drugs is recognized for its patented innovations, such as the CitraVit and Verma-C dialysis solutions enhanced with L-Ascorbic Acid, which help manage oxidative stress and optimize anticoagulation. In addition to its proprietary products, the company offers third-party contract manufacturing (OEM) services and represents international healthcare leaders in the Greek market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Verma Drugs.